Clinical trial
The AOT (Acridine Orange and Taurolidine) Trial
NCT00321165 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00321165 |
|---|---|
| Title | The AOT (Acridine Orange and Taurolidine) Trial |
| Official title | The AOT (Acridine Orange and Taurolidine) Trial: a Survey on Diagnosis and Prevention of Catheter-Related Infections in Patients on Home Parenteral Nutrition |
| Lead sponsor | Radboud University Medical Center, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Parenteral Nutrition, Infection, Sepsis |
| Intervention type | Drug |
| Interventions | taurolidine |
| Enrollment | 60 |
| Start date | Jun 1, 2006 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | May 3, 2006 |
| Last update posted | Feb 11, 2009 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: